Georgia court vacates FDA classifications of MiMedx's AXIOFILL
AI Summary- Georgia district court vacated FDA's classifications of MiMedx's AXIOFILL.
- September 23, 2026, MiMedx announced the ruling and its remand to FDA.
- FDA must reconsider AXIOFILL's minimal-manipulation and product-classification determinations.